Mankind Pharma Ltd (MANKIND) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1003845,
    "name": "Mankind Pharma",
    "stock_name": "Mankind Pharma",
    "full_name": "Mankind Pharma Ltd",
    "name_url": "stocks-analysis/mankind-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,155.90",
    "chg": 88.8,
    "chgp": "4.3%",
    "dir": 1,
    "prev_price": "2,067.10",
    "mcapval": "87,785.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 543904,
    "symbol": "MANKIND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE634S01028",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "7.93 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/mankind-pharma-1003845-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-momentum-3744453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3744453.png",
        "date": "2025-12-03 15:00:12",
        "description": "Mankind Pharma has experienced a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid recent price movements and sector trends. This development comes as the stock trades close to its 52-week low, with volume and futures activity reflecting evolving investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Mankind Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mankind-pharma-technically-bullish-or-bearish-3740546",
        "imagepath": "",
        "date": "2025-12-02 09:14:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Overview of Current Price Action and Trend</strong></p>\n<p>Mankind Pharma’s share price currently stands at ₹2,235.40, slightly down from the previous close of ₹2,251.85. The stock has traded within a daily range of ₹2,224.70 to ₹2,271.95, reflecting modest intraday volatility. Over the past 52 weeks, the stock has seen a high of ₹3,050.00 and a low of ₹2,115.50, indicating a significant drawdown from its peak levels.</p>\n<p>The technical trend’s recent shift from mildly bearish to bearish signals a deterioration in momentum, suggesting that sellers are gaining control. This change is critical for traders and investors who rely on technical analysis to time their entries and exits.</p>\n<p><strong>Technical Indicators: Mixed but Leaning Bearish</strong></p>\n<p>Examining the key technical indi..."
      },
      {
        "title": "Mankind Pharma Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-technical-momentum-shifts-amid-bearish-signals-3740452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_technicaldot_3740452.png",
        "date": "2025-12-02 08:12:59",
        "description": "Mankind Pharma's recent technical indicators reveal a shift in price momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's performance, combined with key technical signals such as MACD, RSI, and moving averages, provides a nuanced picture of its current market stance amid broader index trends."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-action-3738854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3738854.png",
        "date": "2025-12-01 15:00:10",
        "description": "Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid subdued price movement and a broader market environment marked by cautious sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-rise-amid-weak-price-action-3738801",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/MankindPharma_oi_spurts_by_underlying_3738801.png",
        "date": "2025-12-01 14:00:12",
        "description": "Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of subdued price performance and reduced delivery volumes, prompting a closer examination of the underlying market dynamics and potential directional bets."
      },
      {
        "title": "Mankind Pharma Technical Momentum Shifts Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-technical-momentum-shifts-amid-bearish-sentiment-3727719",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_technicaldot_3727719.png",
        "date": "2025-11-25 08:15:25",
        "description": "Mankind Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bearish and bullish signals amid a challenging market backdrop. The stock’s performance contrasts with broader indices, underscoring sector-specific pressures and evolving investor sentiment."
      },
      {
        "title": "Mankind Pharma Sees Notable Surge in Open Interest Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mankind-pharma-sees-sharp-open-interest-surge-amid-bearish-market-signals-3725826",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_oi_spurts_by_underlying_3725826.png",
        "date": "2025-11-24 15:01:31",
        "description": "Mankind Pharma has registered a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid a backdrop of subdued price movement and sector underperformance. This development invites a closer examination of volume patterns, investor sentiment, and potential directional bets shaping the stock’s near-term outlook."
      },
      {
        "title": "Mankind Pharma Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mankind-pharma-downgraded-to-sell-by-marketsmojo-amid-technical-and-financial-concerns-3717218",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/MankindPharma_mojoScore_3717218.png",
        "date": "2025-11-20 08:21:38",
        "description": "Mankind Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive overview of its current standing."
      },
      {
        "title": "Is Mankind Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-mankind-pharma-technically-bullish-or-bearish-3716956",
        "imagepath": "",
        "date": "2025-11-20 08:12:34",
        "description": "As of 19 November 2025, the technical trend has changed from sideways to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and both the weekly and monthly Bollinger Bands confirm a bearish outlook. Daily moving averages also indicate bearish conditions. The KST is mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend on a monthly basis. Overall, the combination of these indicators suggests a prevailing bearish sentiment for Mankind Pharma...."
      }
    ],
    "total": 423,
    "sid": "1003845",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/mankind-pharma-1003845"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "16-Jan-2026",
      "details": "Please find attached Intimation regarding withdrawal and outstanding Credit Ratings granted by ICRA Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "16-Jan-2026",
      "details": "Please find attached intimation regarding Investor Conference Call for Q3 & 9M FY26 with Senior Management",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company",
      "datetime": "09-Jan-2026",
      "details": "Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve approval of unaudited standalone and consolidated financial results of the company for the quarter and nine months ended on December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mankind Pharma Ltd has declared <strong>100%</strong> dividend, ex-date: 08 Aug 25",
          "dt": "2025-08-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-03 15:00:12

Mankind Pharma has experienced a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid recent price movements and sector trends. This development comes as the stock trades close to its 52-week low, with volume and futures activity reflecting evolving investor sentiment in the Pharmaceuticals & Biotechnology sector.

Is Mankind Pharma technically bullish or bearish?

2025-12-02 09:14:18

Overview of Current Price Action and Trend Mankind Pharma’s share price currently stands at ₹2,235.40, slightly down from the previous close of ₹2,251.85. The stock has traded within a daily range of ₹2,224.70 to ₹2,271.95, reflecting modest intraday volatility. Over the past 52 weeks, the stock has seen a high of ₹3,050.00 and a low of ₹2,115.50, indicating a significant drawdown from its peak levels. The technical trend’s recent shift from mildly bearish to bearish signals a deterioration in momentum, suggesting that sellers are gaining control. This change is critical for traders and investors who rely on technical analysis to time their entries and exits. Technical Indicators: Mixed but Leaning Bearish Examining the key technical indi...

Mankind Pharma Technical Momentum Shifts Amid Market Challenges

2025-12-02 08:12:59

Mankind Pharma's recent technical indicators reveal a shift in price momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. The stock's performance, combined with key technical signals such as MACD, RSI, and moving averages, provides a nuanced picture of its current market stance amid broader index trends.

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-01 15:00:10

Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid subdued price movement and a broader market environment marked by cautious sentiment in the Pharmaceuticals & Biotechnology sector.

Mankind Pharma Sees Notable Surge in Derivatives Open Interest Amid Market Volatility

2025-12-01 14:00:12

Mankind Pharma has experienced a significant rise in open interest within its derivatives segment, signalling heightened market activity and evolving investor positioning. This development comes amid a backdrop of subdued price performance and reduced delivery volumes, prompting a closer examination of the underlying market dynamics and potential directional bets.

Mankind Pharma Technical Momentum Shifts Amid Market Challenges

2025-11-25 08:15:25

Mankind Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a complex interplay of bearish and bullish signals amid a challenging market backdrop. The stock’s performance contrasts with broader indices, underscoring sector-specific pressures and evolving investor sentiment.

Mankind Pharma Sees Notable Surge in Open Interest Amid Market Volatility

2025-11-24 15:01:31

Mankind Pharma has registered a significant rise in open interest in its derivatives segment, signalling a shift in market positioning amid a backdrop of subdued price movement and sector underperformance. This development invites a closer examination of volume patterns, investor sentiment, and potential directional bets shaping the stock’s near-term outlook.

Mankind Pharma Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-11-20 08:21:38

Mankind Pharma, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of technical indicators, valuation metrics, financial trends, and quality parameters. This article analyses the factors influencing the recent revision in the company’s assessment, providing investors with a comprehensive overview of its current standing.

Is Mankind Pharma technically bullish or bearish?

2025-11-20 08:12:34

As of 19 November 2025, the technical trend has changed from sideways to bearish. The current stance is bearish with moderate strength. The weekly MACD is bearish, and both the weekly and monthly Bollinger Bands confirm a bearish outlook. Daily moving averages also indicate bearish conditions. The KST is mildly bearish on a weekly basis, while the Dow Theory shows a mildly bearish trend on a monthly basis. Overall, the combination of these indicators suggests a prevailing bearish sentiment for Mankind Pharma....

View All News